梯瓦製藥 TEVA 深滬

等待開盤 09-24 09:30:00 美东时间

39.01

-0.510

-1.29%

華盛通

立即下載

最高40.09
今開39.68
成交量 613.87万股
最低 38.92
昨收 39.52
總市值 454.97亿
52周最高 40.79
市盈率 ^靜 32.18
換手率 0.53%
52周最低 18.825
委比 -11.11%
總股本 11.66亿
歷史最高 69.428
量比 1.17
振幅 2.96%
歷史最低 6.07
每手 1
風險率 5.34%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

内部人交易｜梯瓦制药披露一笔股票减持，金额约10.58万美元

美股上市公司梯瓦制药（TEVA）披露一笔内部人股票交易。文件显示，公司内部人Savage (Brian)（Officer）2026-09-18减持公司股票，交易...

今天 07:02
Viatris, Teva initiated at Outperform at Oppenheimer

Oppenheimer began coverage of Viatris (VTRS) and Teva Pharmaceutical Industries (TEVA) with Outperform ratings for both. The price target for Viatris is $25 (~46% upside based on Sept. 22 close), whil...

今天 00:12
Oppenheimer Initiates Coverage On Teva Pharmaceutical Indus with Outperform Rating, Announces Price Target of $50

Oppenheimer analyst Les Sulewski initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Outperform rating and announces Price Target of $50.

09-23 20:08
【机构持仓】先锋领航资本管理增持梯瓦制药

最新披露的机构持仓数据显示，先锋领航资本管理于最新季度调整了对梯瓦制药（TEVA）的持仓。主要变动如下：持仓变化：增持5049股仓位变化幅度：0.02...

09-17 15:21
梯瓦：仿制药出海浪潮中的耀眼新星

（来源：中国医药报）转自：中国医药报除了中枢神经系统和呼吸系统用药，梯瓦具有特色的创新药产品线主要集中在妇科领域。这些产品主要通过收购默克雪兰诺的妇科药物...

09-17 08:09
美股夜盘 | 浦项钢铁上升3.44%，INNIO N.V上升3.09%

浦项钢铁上升3.44%；INNIO N.V上升3.09%；邦吉上升2.74%

09-15 10:01
Teva Pharmaceutical shares are trading higher. The company announced that its ordinary shares will begin trading directly on the NYSE completing the company’s planned transition from its ADSs program.

Teva Pharmaceutical shares are trading higher. The company announced that its ordinary shares will begin trading directly on the NYSE completing the company’s planned transition from its ADSs program.

09-15 02:48
【机构持仓】Phoenix Financial Ltd增持梯瓦制药

最新披露的机构持仓数据显示，Phoenix Financial Ltd于最新季度调整了对梯瓦制药（TEVA）的持仓。主要变动如下：持仓变化：增持1938...

09-14 15:21
美股夜盘 | 科帕特大升7.32%，甲骨文大升5.41%

科帕特大升7.32%；甲骨文大升5.41%；梯瓦制药上升3.25%

09-11 15:01
梯瓦制药（TEVA）完成49亿美元等值优先票据定价募资用于置换多笔存量债券

金吾资讯

09-10 19:00

派息除權日	每股總股息	派息日期
2017-11-28	0.09	2017-12-12
2017-11-27	0.07	2017-12-12
2017-08-25	0.07	2017-09-14
2017-06-01	0.29	2017-06-22
2017-02-28	0.29	2017-03-20
2016-12-01	0.29	2016-12-20
2016-08-18	0.29	2016-09-08
2016-05-20	0.29	2016-06-07
2016-02-25	0.29	2016-03-14
2015-11-13	0.29	2015-12-03
2015-08-18	0.29	2015-09-03
2015-05-15	0.29	2015-06-04
2015-02-17	0.29	2015-03-03
2014-11-13	0.27	2014-12-02
2014-08-19	0.29	2014-09-04
2014-05-16	0.30	2014-06-02
2014-02-20	0.29	2014-03-10
2013-11-18	0.28	2013-12-03
2013-08-16	0.27	2013-09-03
2013-05-16	0.27	2013-06-03
2013-02-19	0.27	2013-03-07
2012-11-13	0.20	2012-12-03
2012-08-13	0.21	2012-09-04
2012-05-17	0.20	2012-06-04
2012-02-23	0.20	2012-03-15
2011-11-09	0.17	2011-12-07
2011-08-04	0.20	2011-08-25
2011-05-19	0.20	2011-06-07
2011-02-10	0.22	2011-03-07
2010-11-08	0.17	2010-12-06
2010-08-02	0.17	2010-08-26
2010-05-10	0.16	2010-06-04
2010-02-19	0.16	2010-03-17
2009-11-06	0.13	2009-12-04
2009-08-03	0.12	2009-08-27
2009-05-08	0.12	2009-06-03
2009-02-23	0.11	2009-03-19
2008-11-07	0.09	2008-12-05
2008-08-01	0.10	2008-08-27
2008-05-13	0.11	2008-06-05
2008-02-15	0.10	2008-03-13
2007-11-02	0.08	2007-11-28
2007-08-10	0.08	2007-09-06
2007-05-10	0.08	2007-06-05
2007-02-16	0.08	2007-03-15
2006-11-10	0.07	2006-12-06
2006-08-11	0.06	2006-09-08
2006-05-12	0.06	2006-06-07
2006-03-06	0.06	2006-03-30
2005-11-10	0.05	2005-12-07
2005-08-11	0.05	2005-09-07
2005-05-05	0.06	2005-06-01
2005-02-17	0.06	2005-03-17
2004-11-09	0.04	2004-12-06
2004-08-09	0.04	2004-09-07
2004-05-10	0.15	2004-06-07
2004-02-20	0.08	2004-03-22
2003-11-13	0.06	2003-12-12
2003-08-08	0.06	2003-09-08
2003-05-08	0.06	2003-06-06
2003-02-24	0.05	2003-03-24
2002-11-07	0.07	2002-12-06
2002-08-19	0.07	2002-09-16
2002-05-20	0.07	2002-06-17
2002-02-15	0.08	2002-03-18
2001-11-16	0.05	2001-12-17
2001-08-20	0.05	2001-09-17
2001-05-17	0.05	2001-06-15
2001-03-08	0.05	2001-04-06
2000-11-16	0.04	2000-12-15
2000-08-24	0.04	2000-09-21
2000-05-19	0.04	2000-06-19
2000-02-17	0.08	2000-03-27
1999-11-04	0.05	1999-11-30
1999-08-18	0.05	1999-09-13
1999-05-21	0.05	1999-06-15
1999-03-08	0.05	1999-03-30
1998-11-20	0.05	1998-12-11
1998-08-21	0.06	1998-09-11
1998-05-21	0.06	1998-06-22
1998-03-12	0.06	1998-03-31
1997-11-20	0.07	1997-12-09
1997-08-25	0.07	1997-09-11
1997-05-23	0.07	1997-06-12
1997-03-07	0.07	1997-03-26
1996-11-20	0.05	1996-12-09
1996-08-26	0.05	1996-09-12
1996-05-23	0.05	1996-06-12
1996-03-07	0.05	1996-03-26
1995-11-20	0.05	1995-12-07
1995-08-14	0.05	1995-08-30
1995-05-17	0.05	1995-06-07
1995-03-07	0.05	1995-04-04
1994-11-15	0.05	1994-12-13
1994-08-09	0.05	1994-09-12
1994-05-18	0.05	1994-06-21
1994-03-08	0.05	1994-04-05
1993-11-17	0.04	1994-01-03
1993-08-17	0.04	1993-09-14
1993-05-18	0.03	1993-06-21
1993-04-07	0.06	1993-05-05
1992-11-17	0.04	1992-12-21
1992-08-18	0.04	1992-09-21
1991-11-20	0.04	1991-12-19
1991-08-20	0.04	1991-09-19
1991-05-19	0.04	1991-07-19
1991-03-05	0.04	1991-03-28
1990-11-20	0.04	1990-12-20
1990-08-16	0.04	1990-09-17
1989-05-21	0.04	1989-06-18
1988-12-06	0.04	1988-12-30
1988-09-07	0.04	1988-10-05
1988-06-09	0.03	1988-07-19
1988-04-11	0.03	1988-05-15
1988-02-08	0.03	1988-03-10
1987-10-23	0.03	1987-11-19
1987-07-08	0.04	1987-08-04
1987-06-21	0.03	1987-07-13
1987-02-23	0.03	1987-03-26
1985-09-23	0.02	1985-10-21
1985-06-17	0.02	1985-07-15
1984-01-27	0.02	1984-02-29
1982-08-16	0.40	1982-09-13
1982-08-10	0.06	1982-09-13

公司名稱	梯瓦制药
行業分類	制药
業務描述	Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

梯瓦製藥 TEVA 深 滬

39.01

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

梯瓦製藥 TEVA 深滬